LOG IN
|
Services
|
Contact
|
Custom Research
Search
Advanced search
Main
Healthcare, Pharmaceuticals & Biotechnology
Healthcare and drugs
U.S. Diabetes Diagnostic Testing Markets
Publications
Business, Finance & Insurance
(35706)
Consumer Goods & Retail
(127031)
Databases & Statistics
(27)
Education & Consulting
(0)
Industry
(87698)
Healthcare, Pharmaceuticals & Biotechnology
(58540)
Biotechnology
(9100)
Pharmaceuticals
(30490)
Healthcare and drugs
(18950)
Services
(0)
Government and Public Sector
(553)
Technologies & Electronics
(91477)
Company reports
(70860)
Country reports
(2187)
(Currently 512486 Items)
Partners
Healthcare and drugs / REPORT INFORMATION
U.S. Diabetes Diagnostic Testing Markets
Date
Jul, 2001
Pages
0
Price / format
€2825 / Hard Copy
€2449 / Site License
€3579 / Enterprisewide
€2 428
Report Information
|
Custom-Tailored Research
|
Product Trade Lead
Abstract:
Growth of At-Risk Population Sparks Demand for Diabetes Testing
The National Institute for Health estimated that the number of obese Americans has doubled in the last decade. Lack of exercise and poor diet, including foods that are high in fat, are likely to extend this trend for years to come. As physicians treat more and more overweight patients, they will order an increased number of laboratory tests to diagnose and monitor diabetes,
which correlates closely with obesity.
This Frost & Sullivan research analyzes the markets for diagnostic diabetes tests that are conducted in clinical labs, hospitals and physician office labs, including glycohemoglobin and lab-based glucose tests. By tracking trends and assessing their impact on the future of the industry, this study offers its users a privileged view of the marketplace.
Point-of-Care Technology Potential Challenge for Laboratory Tests
Point-of-care testing could eliminate laboratory testing in the long term, says the author of this research. The ability for nurses and other non-laboratory personnel to perform diabetes tests in a physician's office or at the hospital bedside could reduce the volume of laboratory-analyzed testing.
Point-of-care testing provides faster diagnoses, allowing physicians to discuss diet, exercise, and medication recommendations the same day.
Currently, point-of-care procedures have not significantly penetrated the market. But the analyst warns, If point-of-care testing becomes less expensive, easier to use, and more accurate, that could change. This study identifies market drivers and restraints, helping your company anticipate and overcome any obstacles that may lie ahead.
Laboratory Consolidation Decreases Customer Base for Test Manufacturers
Consolidation of clinical laboratories that began in the late 1980s is still ongoing, says the analyst. As long as this consolidation trend continues, the customer base for diabetes tests will shrink.
With fewer potential clients, reagent providers will be forced to comply to laboratory demands for reduced pricing. In this marketplace, the supplier that can provide the least expensive reagents and still meet the testing requirements is often selected. This research examines competitive strategies in the reagent and laboratory industries, enabling your firm to develop an
effective business plan.
Additional Information
Market Participants
Abbott Laboratories
Agilent Technologies
Bayer Corp.
Beckman Coulter
Bio-Rad Laboratories
Cholestech Corp.
Dade-Behring Ltd.
DAKO
Diagnostic Chemicals Ltd.
ESA, Inc.
Flexite Diagnostics, Inc.
Helena
Hoffman-LaRoche Ltd.
Home Diagnostics, Inc.
Horizon Diagnostics, Inc.
Instrumentaiton Lab
Johnson & Johnson
Kenlor Industries
KIVALO
Lifescan, Inc.
LXN Corp.
Matsushita Electric
MIT Service, Inc.
Nova Biomedical Corp.
Oakhill Capital
Olympus America, Inc.
Omega Diagnostics Ltd.
PerkinElmer, Inc.
Primus
Radiometer Medical A/S
Sanwa Research Institute
Sarnoff Corp.
Schiapparelli
Stanbio Laboratories
Wako Chemicals USA, Inc.
WBS Warburg Dillon
World Diagnostics, Inc.
Yamanouchi Pharma Ltd.
Table of contents:
1. Total Market Analysis
A. Market Overview and Definitions
B. Market Engineering Research and Measurement Analysis
C. Market Drivers
D. Market Restraints
E. Revenue Forecasts
F. Demand Analysis
G. Market and Technology Trends
H. Competitive Structure
I. Market Share Analysis
J. Supplement
2. U.S. Glycohemoglobin Test Market
A. Market Overview and Definitions
B. Market Engineering Research and Measurement Analysis
C. Challenges Facing the U.S. Glycohemoglobin Test Market
D. Market Drivers
E. Market Restraints
F. Revenue Forecasts
G. Demand Analysis
H. Market and Technology Trends
I. Pricing Trends
J. Competitive Structure
K. Market Share Analysis
L. Product Analysis
M. Strategic Recommendations
N. ME Awards
O. Supplement
3. U.S. Laboratory-Based Glucose Test Market
A. Market Overview and Definitions
B. Market Engineering Research and Measurement Analysis
C. Challenges
D. Market Drivers
E. Market Restraints
F. Revenue Forecasts
G. Demand Analysis
H. Market and Technology Trends
I. Pricing Trends
J. Competitive Structure
K. Market Share Analysis
L. Product Analysis
M. Strategic Recommendations
N. ME Awards
O. Supplement
List Of Figures
Chapter 1
Total Diabetes Laboratory Test Market: Market Engineering Measurements (U.S.), 2000
Chapter 2
Diabetes Laboratory-Based Test Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2007
Diabetes Laboratory-Based Test Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2007
Diabetes Laboratory-Based Test Market: Revenues and Growth Rates (U.S.), 1997-2007
Diabetes Laboratory-Based Test Market: Percent of Revenues by Product Type (U.S.), 1997-2007
Chapter 4
Diabetes Laboratory-Based Test Market: Competitive Structure (U.S.), 2000
Diabetes Laboratory-Based Test Market: Database of Key Industry Participants by Product Type (U.S.), 2000
Diabetes Laboratory-Based Test Market: Market Share Trends of Major Market Participants (U.S.), 1999-2000
Laboratory-Based Diabetes Test Market: Ten Most Important Market Elements to Integrate into Business Planning (U.S.), 2001
Laboratory-Based Diabetes Test Market: Ten-Point Checklist of Market Engineering Implementation (U.S.), 2001
Laboratory-Based Diabetes Test Market: Ten Elements of a Successful Monitoring Program (U.S.), 2001
Laboratory-Based Diabetes Test Market: Ten Ways to Maximize the Value of This Report (U.S.), 2001
Laboratory-Based Diabetes Test Market: Key Elements to Include in the Market Monitoring Program (U.S.), 2001
Chapter 5
Estimated Diagnosed Diabetic Population (U.S.), 1997-2007
Glycohemoglobin Test Market: Market Engineering Research Methodology (U.S.), 2000
Glycohemoglobin Test Market: Breakdown of Interviews (U.S.), 2001
Glycohemoglobin Test Market: Market Engineering Measurements (U.S.), 2000
Chapter 6
Glycohemoglobin Test Market: Impact of Top Ten Industry Challenges (U.S.), 2001-2007
Glycohemoglobin Test Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2007
Glycohemoglobin Test Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2007
Chapter 7
Glycohemoglobin Test Market: Market Revenues (U.S.), 1997-2007
Glycohemoglobin Test Market: Tests Performed (U.S.), 1997-2007
Glycohemoglobin Test Market: Percent of Revenues by Product Type (U.S.), 1997-2007
Glycohemoglobin Test Market: Percent of Tests by Product Type (U.S.), 1997-2007
Chapter 8
Glycohemoglobin Test Market: Competitive Structure (U.S.), 2000
Glycohemoglobin Test Market: Market Share (by Revenue) Trends of Major Market Participants (U.S.), 1999-2000
Glycohemoglobin Test Market: Market Share (by Tests Performed) Trends of Major Market Participants (U.S.), 1999-2000
Chapter 9
Glycohemoglobin Test Market: Products Offered by Major Market Participants (U.S.), 2000
Glycohemoglobin Test Market: Impact of Top Ten Challenges on Business Functions (U.S.), 2001-2007
Glycohemoglobin Test Market: Impact of Top Ten Industry Drivers on Business Functions (U.S.), 2001-2007
Glycohemoglobin Test Market: Impact of Top Ten Industry Restraints on Business Functions (U.S.), 2001-2007
Glycohemoglobin Test Market: Impact of Top Ten Market Measurements on Business Functions (U.S.), 2001-2007
Glycohemoglobin Test Market: Ten Most Important Market Elements to Integrate into Business Planning (U.S.), 2001
Chapter 10
Laboratory-Based Glucose Test Market: Market Engineering Research Methodology (U.S.), 2001
Laboratory-Based Glucose Test Market: Market Engineering Measurements (U.S.), 2001
Chapter 11
Laboratory-Based Glucose Test Market: Impact of Top Industry Challenges (U.S.), 2001-2008
Laboratory-Based Glucose Test Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2008
Laboratory-Based Glucose Test Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2008
Chapter 12
Laboratory-Based Glucose Test Market: Market Revenues (U.S.), 1998-2008
Laboratory-Based Glucose Test Market: Tests Performed (U.S.), 1998-2008
Chapter 13
Laboratory-Based Glucose Test Market: Competitive Structure (U.S.), 2001
Laboratory-Based Glucose Test Market: Market Share (by Reagent Revenue) Trends of Major Market Participants (U.S.), 1999-2000
Chapter 14
Laboratory-Based Glucose Test Market: Products Offered by Market Participants (U.S.), 2001
Laboratory-Based Glucose Test Market: Impact of Top Industry Challenges on Business Functions (U.S.), 2001-2008
Laboratory-Based Glucose Test Market: Impact of Top Industry Drivers on Business Functions (U.S.), 2001-2008
Laboratory-Based Glucose Test Market: Impact of Top Industry Restraints on Business Functions (U.S.), 2001-2008
Laboratory-Based Glucose Test Market: Impact of Top Market Measurements on Business Functions (U.S.), 2001-2008
Order this report
Company name:
Contact person:
Phone/fax:
Email:
Comments:
Product Trade Lead
0 leads found
Add New Buy/Sell Lead
Type:
Buy
Sell
Offer:
Contacts:
Capture:
© 2007-2010 MarketReportFinder.com